Intercept Pharmaceuticals (NASDAQ:ICPT) Coverage Initiated at StockNews.com
StockNews.com assumed coverage on shares of Intercept Pharmaceuticals (NASDAQ:ICPT – Free Report) in a research note released on Saturday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Several other equities analysts have also issued reports on ICPT. Canaccord Genuity Group reiterated a hold rating and issued a $19.00 price objective (down from […]
More Stories
What to Know About Trump’s 1st State of the Union Address of His 2nd Term
By Joseph Lord President Donald Trump will address both chambers of Congress on Feb. 24 in what will be his...
Winter Storm Hernando ‘Bombs Out,’ Knocks Out Power To 600,000+ In Northeast; 10,000 Flights Canceled
By Seam Breslin and Jenn Jordan Snow is piling up rapidly and powerful winds are making the situation worse for...
EU Urges US to Honor Terms of Trade Deal After Supreme Court Ruling
By Aldgra Fredly The European Commission said on Feb. 22 it wants “full clarity” from the United States after a...
Top Cartel Leader ‘El Mencho’ Killed in Mexican Military Operation, US Official Says
By Jack Phillips The notorious leader of the Jalisco New Generation Cartel was killed during a Mexican government operation on...
Secret Service Agents Fatally Shoot Man Trying to Unlawfully Enter Mar-a-Lago
By Jacki Thrapp A man in his 20s was shot and killed by Secret Service agents on Feb. 22 as...
US Beats Canada for First Men’s Hockey Olympic Gold Since 1980
By The Associated Press MILAN—No miracle needed. The United States is on top of the hockey world for the first...